HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Fine Gael to hold June event to commemorate centenary of former Taoiseach Garret FitzGerald
Fine Gael is to mark the 100th anniversary of the birth of former Taoiseach Garret FitzGerald with a special event…
30th May 2026Statement from Tánaiste on Dublin Central and Galway West bye-elections
"I want to thank the people who have voted for Fine Gael in these bye-elections. In both constituencies we ran…
23rd May 2026Expand the CCTV litter scheme – McAdam
The CCTV scheme that aims to deter illegal dumping should be rolled out across the city centre, the Lord Mayor…
19th May 2026